SCHEMBL8949241

SCHEMBL8949241

COC(=O)[C@H]1CC[C@H](NC(=O)c2cnnc(-c3ccc(C#N)cc3)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MAPK14 Q16539 2/20 0.44
MAPK11 Q15759 1/20 0.44
EGLN1 Q9GZT9 10/20 0.43
TTK P33981 1/20 0.42
CFTR P13569 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
XDH P47989 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
CHEK1 O14757 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8949251 1.00 NPC1 (0.45) NPC1RAB9AMAPK14MAPK11EGLN1
SCHEMBL8949194 0.84 F2 (0.46) MAPK14CFTR
Hydrochloric Acid SCHEMBL8949030 0.83 F2 (0.45) MAPK14CFTR
SCHEMBL8409339 0.83 NPC1 (0.61) NPC1RAB9AMAPK14MAPK11EGLN1
SCHEMBL8948987 0.81 CASP1 (0.54) NPC1RAB9AEGLN1CFTRIRAK4
SCHEMBL8948991 0.81 CASP1 (0.54) NPC1RAB9AEGLN1CFTRIRAK4
SCHEMBL8949256 0.76 EGLN1 (0.45) RAB9AEGLN1TTKCFTRIRAK4
SCHEMBL8949141 0.76 EGLN1 (0.45) RAB9AEGLN1TTKCFTRIRAK4
SCHEMBL8949262 0.76 EGLN1 (0.45) RAB9AEGLN1TTKCFTRIRAK4
SCHEMBL8949333 0.76 HCRTR2 (0.41) MAPK14EGLN1TTKCFTRIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563268-A FOR PREVENTING CELL AGGLOMERATION, TREATING THROMBOSIS, ARTERIOSCLEROSIS, BRAIN, LUNG OR CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-10-08 US disclosed
US-5418233-A FOR INHIBITING CELL AGGREGATION KARL THOMAE GMBH (DE) 1995-05-23 US disclosed
EP-0537696-A1 Heterobiaryl derivatives, medicines containing those compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-04-21 EP disclosed